AI IntelligenceJun 20, 2026Secondary Market
Article
ADMA
ADMA Biologics was hit with a federal securities lawsuit over alleged revenue inflation. The lawsuit accuses the company of artificially inflating its financial results.
Data Cube AI EditorialSource: Yahoo Finance
01
Source Brief
ADMA Biologics was hit with a federal securities lawsuit over alleged revenue inflation. The lawsuit accuses the company of artificially inflating its financial results.
02